DRI HEALTHCARE TRUST (DHT-U.CA) Stock Price, Forecast & Analysis
Canada - TSX:DHT-U - CA23344H1091
DHT-U.CA Key Statistics, Chart & Performance
The current stock price of DHT-U.CA is 11.3 USD. In the past month the price increased by 29.82%. In the past year, price increased by 4.59%.
DHT-U.CA Latest News, Press Relases and Analysis
DHT-U.CA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| BHC.CA | BAUSCH HEALTH COS INC | 1.65 | 3.26B | ||
| TLRY.CA | TILRAY BRANDS INC | N/A | 1.71B | ||
| CRON.CA | CRONOS GROUP INC | 24.64 | 1.32B | ||
| DHT-UN.CA | DRI HEALTHCARE TRUST | 7.39 | 885.25M | ||
| GUD.CA | KNIGHT THERAPEUTICS INC | 122.8 | 612.04M | ||
| WEED.CA | CANOPY GROWTH CORP | N/A | 510.76M | ||
| ACB.CA | AURORA CANNABIS INC | N/A | 339.75M | ||
| CPH.CA | CIPHER PHARMACEUTICALS INC | 20.55 | 332.96M | ||
| HITI.CA | HIGH TIDE INC | N/A | 331.47M | ||
| OGI.CA | ORGANIGRAM GLOBAL INC | N/A | 283.44M | ||
| NGEN.CA | NERVGEN PHARMA CORP | N/A | 244.46M | ||
| XLY.CA | AUXLY CANNABIS GROUP INC | 4 | 215.72M |
Related stock screener links
DRI HEALTHCARE TRUST / DHT-U.CA FAQ
What does DHT-U do?
DRI Healthcare Trust is an unincorporated open-ended company. The company is headquartered in Toronto, Ontario and currently employs 36 full-time employees. The company went IPO on 2021-02-11. The firm provides capital to universities and research institutions, academic institutions, biotechnology companies and pharmaceutical companies. The company acquires more than 75 royalties on 45-plus drugs, including Ekterly, Eylea, Keytruda, Orserdu, Remicade, Spinraza, Stelara, Vonjo and Zytiga. Its portfolio includes Empaveli/Syfovre, Eylea I, Eylea II, Natpara, Omidria, Oracea, Orserdu I, Orserdu II, Rydapt, Spinraza, Stelara, Vonjo I, Vonjo II, Xenpozyme, Xolair, Zejula, Zytiga, and other products. Its therapeutic areas include oncology, neurology, ophthalmology, endocrinology, hematology, dermatology, lysosomal storage disorders (LSD) and immunology. The firm is managed by DRI Capital Inc. Its products are marketed by pharmaceutical companies, including Regeneron, Bayer, Santen; AstraZeneca; Galderma, and others.
What is the current price of DHT-U stock?
The current stock price of DHT-U.CA is 11.3 USD. The price increased by 7.52% in the last trading session.
How is the ChartMill rating for DRI HEALTHCARE TRUST?
DHT-U.CA has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
DHT-U.CA Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to DHT-U.CA. When comparing the yearly performance of all stocks, DHT-U.CA turns out to be only a medium performer in the overall market: it outperformed 60.74% of all stocks.